Study of BL-M08D1 for advanced head and neck cancer
Part of Cancer clinical trials.
This study tests an experimental drug called BL-M08D1 for people with head and neck cancer that has returned or spread. The drug is designed to target and destroy cancer cells, and the study will check if it is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have head and neck squamous cell carcinoma that is recurrent or metastatic.
- You must have a tumor sample available or agree to provide one.
- Your cancer must be measurable by standard imaging.
- You must be in good overall health (able to do light activity).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, BL-B16D1, for people with advanced head and neck cancer or other solid tumors that have not been helped by standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug called BL-M08D for people with advanced digestive tract tumors or other solid tumors that have spread. It aims to see if the drug can shrink tumors and improve survival, while monitoring safety.
This trial studies an experimental drug called BL-M09D1. It is given to people with certain gynecologic cancers and other solid tumors that have advanced and not responded to standard treatment. The goal is to see if the drug can help shrink or control the cancer.
This trial tests an experimental drug called BL-M08D1 for people with solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug, BL-M09D1, in people with advanced non-small cell lung cancer or other solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the cancer.
This trial tests two new drugs, BL-B01D1 and SI-B003, alone or together, for people with head and neck squamous cell carcinoma that has come back or spread. It may also include other solid tumors. The goal is to see if these drugs can shrink tumors or slow their growth.
Hear when a new Head and Neck Squamous Cell Carcinomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.